ArticleOncology reports2024

ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells.

Xiaoning Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.